Fundraising Fox

VST BIO

San Diego, US · Delaware corporation

Biotech

Founders & leadership

RL
Rebecque LabaExecutive
KZ
Krisztina ZseboinExecutive

Board

DC
David ChereshBoard director
WS
William SessaBoard director
JA
J. Anthony WareBoard director
CS
Chris SomervilleBoard director

Reported raises · per SEC filings

Form D private placements

$31.9M disclosed across 1 round · 2025

▶$31.9MraisedApr 2026 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • David ChereshDirector
  • Rebecque LabaExecutive Officer
  • William SessaDirector
  • J. Anthony WareDirector
  • Chris SomervilleDirector
  • Krisztina ZseboExecutive Officer, Director
Offering amount
$31.9M
Amount sold
$31.9M
First sale
Nov 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

VST BIO Secures $45 Million Series A Funding to Advance Stroke Therapy | Raising.firaising.fi · Mar 2026VST BIO: $45 Million Series A Raised To Advance Stroke Therapeutic VB-001pulse2.com · Mar 2026Medpathtrial.medpath.com · Mar 2026VST BIO Corporation Announces Series A Financing to Advance VB-001 and Adds William Sessa to Board of Directorsprnewswire.com · Mar 2026VST BIO Corporation Raises $45M in Series A Financing - San Diego Todaynationaltoday.com · Mar 2026VST BIO Closes Series A Fundingfinsmes.com · Mar 2026

Frequently asked questions

How much funding has VST BIO raised?
VST BIO has disclosed $31.9M raised across 1 round.
Where is VST BIO headquartered?
VST BIO is headquartered in San Diego, US.